Roaccutane in medicines safety update

The TGA has issued a reminder to health professionals about the potential risks of psychiatric adverse risks associated with isotretinoin (Roaccutane) and the need for careful psychological assessment before and during the treatment.The warning is based on a TGA evaluation of the findings of a UK Medicines and Healthcare Products Regulatory Agency report about the